FLGT compared with AKBA: revenue, margins and what each company keeps, and the suppliers and customers both name

FLGTFulgent Genetics, Inc.

Mkt capRevenueRevenue

AKBAAkebia Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

FLGTFulgent Genetics, Inc.

AKBAAkebia Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

FLGTFulgent Genetics, Inc.

20.59▼−5.04%· post 20.59

Mkt cap$567.4MRevenue$85MQ2 FY26Revenue$323MFY25

AKBAAkebia Therapeutics, Inc.

0.74▲+0.20%· post 0.71

ClosedOct 30 '26

Mkt cap$195.8MRevenue$49MQ2 FY26Revenue$236MFY25

Compare

ClosedOct 30 '26

FLGTFulgent Genetics, Inc.

AKBAAkebia Therapeutics, Inc.

20.59▼−5.04%post 20.59

Price

0.74▲+0.20%post 0.71

$567.4M

Mkt cap

$195.8M

Q2 FY26$85M

Revenue

$49MQ2 FY26

FY25$323M

Revenue

$236MFY25

FLGT20.59▼−5.04%vsAKBA0.74▲+0.20%ClosedOct 30 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

FLGT, solidAKBA, dashed

Supply-chain overlap

Revenue flow

FLGT: latest quarter is a loss; flow not drawable. AKBA: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only FLGT 4

ABTAbbott Laboratoriessupplier

ILMNIlluminasupplier

—Leica Biosystemsunlistedsupplier

—Rocheunlistedsupplier

Shared 0

No shared counterparties.

Only AKBA 21

CAHCardinal Healthsupplier

DVADaVitacustomer

QTTBQ32 Biosupplier

CYCNCyclerion Therapeuticssupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

17 more · AKBA chain ›